Philippines - English - FDA (Food And Drug Administration)

n/a; importer: zydus healthcare philippines inc; distributor: metro drug inc. - levetiracetam - film-coated tablet - 1 g

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: zydus healthcare philippines, inc.; distributor: metro drug, inc. - risperidone - film-coated tablet - 2 mg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: zydus healthcare philippines, inc.; distributor: metro drug, inc. - risperidone - film-coated tablet - 3 mg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: zydus healthcare philippines inc.; distributor: metro drug inc - montelukast (as sodium) - chewable tablet - 5 mg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: zydus healthcare philippines inc.; distributor: metro drug inc - olanzapine - film-coated tablet - 5 mg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: zydus healthcare philippines, inc.; distributor: metro drug, inc - clopidogrel (as bisulfate) - film-coated tablet - 75 mg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: zydus healthcare philippines inc.; distributor: metro drug inc - risperidone - tablet - 1 mg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: zydus healthcare philippines, inc; distributor: metro drug, inc - irbesartan - film-coated tablet - 150 mg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: zydus healthcare philippines inc.; distributor: metro drug inc. - irbesartan - film-coated tablet - 300 mg

United States - English - NLM (National Library of Medicine)

zydus pharmaceuticals usa inc. - venlafaxine hydrochloride (unii: 7d7rx5a8mo) (venlafaxine - unii:grz5rcb1qg) - venlafaxine 25 mg - venlafaxine tablets, usp are indicated for the treatment of major depressive disorder. the efficacy of venlafaxine tablets, usp in the treatment of major depressive disorder was established in 6 week controlled trials of adult outpatients whose diagnoses corresponded most closely to the dsm-iii or dsm-iii-r category of major depression and in a 4 week controlled trial of inpatients meeting diagnostic criteria for major depression with melancholia (see clinical trials ). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the efficacy of ven